Drug Type Antibody |
Synonyms- |
Target |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lymphoproliferative Disorders | Discovery | - | 03 Oct 2024 | |
Neoplasms | Discovery | - | 03 Oct 2024 | |
Systemic Inflammatory Response Syndrome | Discovery | - | 03 Oct 2024 |